Gender-affirming hair removal, mental health outcomes
Research News Release
EurekAlert! provides eligible reporters with free access to embargoed and breaking news releases.
Eligibility GuidelinesEurekAlert! offers eligible public information officers paid access to a reliable news release distribution service.
Eligibility GuidelinesEurekAlert! is a service of the American Association for the Advancement of Science.
What The Study Did: In this analysis of the 2015 U.S. Transgender Survey, gender-affirming hair removal procedures were associated with lower odds of past-month severe psychological distress, past-year smoking and past-year suicidal ideation.
Wearable devices can detect people's stress, according to new Washington State University research, opening potential new interventions for people with addictions. In a paper in the Journal of Medical Internet Research, a WSU research team found that wearable wristbands measure physiological responses to stress in real-time and real-world situations, providing a potential method to help people avoid slipping back into old behaviors.
A new scoping review found that those with chronic health concerns, such as diabetes, heart disease, cancer, and autoimmune conditions, are not only at a higher risk of severe COVID-19 infection, they are also more likely to experience anxiety, depression or substance use during the COVID-19 pandemic.
Curtin University research has found quit support for smoking mothers should continue even after their first babies are born, given that many of those women will become pregnant again, and that quitting can substantially reduce the risk of future preterm births.
A Canadian study reveals that lesbian, gay and bisexual youth are more likely than heterosexual youth to increase their use of cannabis following an increase in their symptoms of depression.
In a perspective published in Neuropsychopharmacology, leaders from the National Institutes of Health address how using appropriate language to describe mental illness and addiction can help to reduce stigma and improve how people with these conditions are treated in health care settings and throughout society. The authors define stigma as negative attitudes toward people that are based on certain distinguishing characteristics.
A new study by Vanderbilt University Medical Center researchers of more the 400,000 Medicare patients taking medications for insomnia found that the risk of death is increased when either benzodiazepines or "z-drugs" are taken with opioids.
More than 75% of women with Opioid Use Disorder report having had an unintended pregnancy, but they are less likely to use effective contraception compared to women who do not use drugs. Results from a multi-year trial found that a two-part intervention featuring co-located contraceptive services in opioid treatment programs and financial incentives could offer an effective solution.
High-dose buprenorphine therapy, provided under emergency department care, is safe and well tolerated in people with opioid use disorder experiencing opioid withdrawal symptoms, according to a study supported by the National Institutes of Health's National Institute on Drug Abuse (NIDA) through the Helping to End Addiction Long-term Initiative, or the NIH HEAL Initiative.
Combined perceptions of the risk and availability of cannabis influence the risk of cannabis use more than perceived risk and perceived availability alone, according to a new Columbia study. Researchers observed that those who perceived cannabis as low-risk and available were more likely to report using the drug in the past year and almost daily compared to those individuals who perceived cannabis as high-risk and unavailable. This is the first study to consider the joint effects of perceived risk and perceived availability.